Funding for this research was provided by:
National Institute of Health (5RO1 AR080416-02)
The University of Tokyo
Article History
Accepted: 3 July 2023
First Online: 2 August 2023
Declarations
:
: D. T. B. is an inventor listed on patents owned by Yale University for therapeutics treating <i>ENPP1</i> deficiency, and is an equity holder and receives research and consulting support from Inozyme Pharma, Inc.
: This article does not contain any studies with human or animal subjects performed by any of the authors.